2023-06-29 08:43:48 ET
- Marpai ( NASDAQ: MRAI ) has confirmed its revenue guidance for Q2 2023 as between $9.5M to $9.8M vs. consensus of $9.51M .
- The Company also expects improvement in the second quarter's EBITDA and net income compared to the EBITDA and net income reported for the Q1 2023.
- "The expected improvements in our profitability metrics are evident even as we continue to make targeted investments in products that help our members live healthier lives, while helping our clients save money on their healthcare spend." said Edmundo Gonzalez, CEO.
For further details see:
Marpai still sees Q2 revenue $9.5M-$9.8M vs. consensus of $9.51M